← Eichor
Study identifier: NCT07435909 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Bupivacaine for Postoperative Pain After Laparoscopic Hysterectomy

Condition: Postoperative Pain  ·  Sponsor: Serkan Kumbasar

PhaseNA
Planned participants120
Who can joinFemale, 35 Years to 75 Years
Healthy volunteersNo

About this study

This prospective, randomized, single-blind controlled study aims to evaluate the effect of bupivacaine injection at trocar entry sites and the vaginal cuff on postoperative pain in patients undergoing total laparoscopic hysterectomy for benign gynecologic conditions. Postoperative pain after laparoscopic hysterectomy may arise from trocar insertion sites and surgical manipulation of the vaginal cuff. Local anesthetic infiltration may reduce somatic pain and improve early recovery. Eligible patients will be randomly assigned to either receive 0.5% bupivacaine injection at trocar sites and the vaginal cuff at the end of surgery or receive no local anesthetic injection (control group). All patients will receive standard postoperative analgesia. Postoperative pain will be assessed using the Visual Analog Scale (VAS) at 1, 2, 3, 6, 12, and 24 hours after surgery. Secondary outcomes include additional analgesic requirement, time to first mobilization, time to first flatus, length of hospital stay, and postoperative complications.

This description comes directly from the study's public registry record.

Talk to the study team

serkan kumbasar, md  ·  5067873216  ·  drserkankumbasar@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

SBÜ Gaziosmanpaşa Training and Research HospitalIstanbul, Gaziosmanpaşa, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07435909